Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001 von Hammond, Terese Catherine, Lee, Raymond C, Oronsky, Bryan, Reid, Tony R, Caroen, Scott, Juarez, Tiffany M, Gill, Jaya, Heng, Annie, Kesari, Santosh

Volltext

Secondary Analysis of RRx-001 on the Incidence of Related Toxicities in Patients Treated with Concomitant Chemoradiation for Locally Advanced Head and Neck Cancer von Reid, T., Oronsky, B., Caroen, S., Abrouk, N., Sonis, S.

Volltext

Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man—PFS2: A Measure of Therapeutic Action-At-A-Distance von Oronsky, Bryan, Carter, Corey A, Reid, Tony R, Scicinski, Jan, Oronsky, Arnold, Lybeck, Michelle, Caroen, Scott, Stirn, Meaghan, Oronsky, Neil, Langecker, Peter

Volltext

Initial Clinical and Advanced Imaging Outcomes from a Multi-Institutional Phase I Dose-Escalation Trial of RRx-001 Plus Whole Brain Radiation for Patients with Brain Metastases von Kim, M.M., Parmar, H., Aryal, M.P., Schipper, M., Devasia, T.P., Kesari, S., Morikawa, A., Spratt, D.E., Junck, L., Hayman, J.A., Lawrence, T.S., Tsien, C., Aiken, R., Goyal, S., Knox, S.J., Caroen, S., Carter, C., Oronsky, B., Cao, Y., Lao, C.

Volltext

O3.8Early Results: "ROCKET" a phase II Study of RRx-001, a novel triple epigenetic inhibitor, Resensitization to Irinotecan in Colorectal Cancer von Carter, C, Reid, T, Fisher, G, Cho-Phan, C, Kunz, P, Kaiser, H, Oronsky, B, Fanger, G, Caroen, S, Parker, C, Scicinski, J

Volltext

Early Results: “ROCKET” a phase II Study of RRx-001, a novel triple epigenetic inhibitor, Resensitization to Irinotecan in Colorectal Cancer von Carter, C., Reid, T., Fisher, G., Cho-Phan, C., Kunz, P., Kaiser, H., Oronsky, B., Fanger, G., Caroen, S., Parker, C., Scicinski, J.

Volltext

Supplementary Material for: Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma Patient von S., Kesari, J., Williams, E., Burbano, M., Stirn, S., Caroen, B.T., Oronsky, T., Reid, C., Larson

Volltext bestellen

Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1 von Johnson, Louise A, Banerji, Suneale, Lawrance, William, Gileadi, Uzi, Prota, Gennaro, Holder, Kayla A, Roshorm, Yaowaluck M, Hanke, Tomáš, Cerundolo, Vincenzo, Gale, Nicholas W, Jackson, David G

Volltext

What Exactly Is Inflammation (and What Is It Not?) von Oronsky, Bryan, Caroen, Scott, Reid, Tony

Volltext

Nucleocapsid as a next-generation COVID-19 vaccine candidate von Oronsky, Bryan, Larson, Christopher, Caroen, Scott, Hedjran, Farah, Sanchez, Ana, Prokopenko, Elena, Reid, Tony

Volltext

Abstract 10336: Phase 3 Anticancer Agent, RRx-001, Ameliorates Hypoxia-Induced Pulmonary Hypertension von Cabrales, Pedro, Reid, Tony, Caroen, Scott, Oronsky, Bryan

Volltext

RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist von Oronsky, Bryan, Takahashi, Lori, Gordon, Richard, Cabrales, Pedro, Caroen, Scott, Reid, Tony

Volltext

Phase 1 pilot study of RRx-001 + nivolumab in patients with advanced metastatic cancer (PRIMETIME) von Reid, Tony, Oronsky, Bryan, Caroen, Scott, Quinn, Mary, Williams, Jeannie, Cabrales, Pedro, Abrouk, Nacer

Volltext

Cardioprotection from Acute Myocardial Infarction with RRx-001, an NLRP3 Inflammasome Inhibitor, in Phase 3 for the Treatment of Cancer von Cabrales, Pedro, Reid, Tony, Caroen, Scott, Oronsky, Bryan

Volltext

Phase 3 Anticancer Agent, RRx-001, Ameliorates Hypoxia-Induced Pulmonary Hypertension von Cabrales, Pedro, Reid, Tony, Caroen, Scott, Oronsky, Bryan

Volltext

A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma von Fine, Howard, Reid, Tony, Caroen, Scott, Oronsky, Bryan, Abrouk, Nacer, Butowski, Nicholas

Volltext

Lost at SCLC: a review of potential platinum sensitizers von Oronsky, Bryan, Abrouk, Nacer, Mao, Li, Shen, Yunle, Wang, Xiaohui, Zhao, Luyang, Caroen, Scott, Reid, Tony

Volltext

Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply von Oronsky, Bryan, Larson, Christopher, Caroen, Scott, Reid, Tony R.

Volltext

The direct NLRP3 inhibitor and Phase 3 small molecule anticancer agent, RRx‐001, protects aged triple transgenic Alzheimer’s disease model mice from CNS degeneration and cognitive... von Reid, Tony, Oronsky, Bryan, Caroen, Scott, Cabrales, Pedro

Volltext

KEVLAR: A phase 2b, multi-institutional, randomized, blinded, controlled trial to assess the safety and efficacy of two schedules of RRx-001 vs. standard of care in attenuating sev... von Reid, Tony R., Oronsky, Bryan, Caroen, Scott, Abrouk, Nacer, Stirn, Meaghan, Sonis, Stephen T.

Volltext